K. Moores

Abnormal frontal and parietal activity during working memory updating in post-traumatic stress disorder (2005)

Weber, D. L., Clark, C. R., McFarlane, A. C., Moores, K., Morris, P. L. P., Egan, G. F.

Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor.

Rice, S Q, Southan, C, Boyd, H F, Terrett, J A, MacPhee, C H, Moores, K, ...

Using expressed sequence tag (EST) homology screening, a new human serine dependent phospholipase A2 (HSD-PLA2) was identified that has 40% amino acid identity with human low density...

Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor.

Rice, S Q, Southan, C, Boyd, H F, Terrett, J A, MacPhee, C H, Moores, K, ...

Using expressed sequence tag (EST) homology screening, a new human serine dependent phospholipase A2 (HSD-PLA2) was identified that has 40% amino acid identity with human low density...

The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function.

Murray, K. J., England, P. J., Hallam, T. J., Maguire, J., Moores, K., Reeves, M. L., ...

1. The effects of siguazodan (SK&F 94836) a selective phosphodiesterase (PDE) inhibitor with inotropic and vasodilator activity, were studied on human platelets. 2. Siguazodan selectively inhibited...